Cargando…

Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis

BACKGROUND: Although studies reported increased cardiovascular (CV) risks in patients treated with macrolides, the risks remain controversial among clarithromycin (CLR) users. We aimed to summarize the association between CLR use and the risks of mortality and CV events. METHODS: We searched PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Ching-Hui, Lin, Cheng-Kuan, Chen, Po-Hua, Park, Suna, Chen, Yi-Yun, Khan, Nazleen, Papatheodorou, Stefania I., Chen, Szu-Ta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934307/ https://www.ncbi.nlm.nih.gov/pubmed/31881052 http://dx.doi.org/10.1371/journal.pone.0226637

Ejemplares similares

Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self‐controlled study designs
por: Root, Adrian A., et al.
Publicado: (2016)

Cardiac events after using clarithromycin for anti-Helicobacter pylori therapy in patients with coronary artery disease
por: Lin, Cheng-Kuan, et al.
Publicado: (2023)

Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study
por: Berni, Ellen, et al.
Publicado: (2017)

Clarithromycin Culprit of Benign Intracranial Hypertension
por: Khan, Habib Rehman, et al.
Publicado: (2015)

Association of non-invasive measures of subclinical atherosclerosis and arterial stiffness with mortality and major cardiovascular events in chronic kidney disease: systematic review and meta-analysis of cohort studies
por: Kouis, Panayiotis, et al.
Publicado: (2019)

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021)

Association of sclerostin with cardiovascular events and mortality in dialysis patients
por: Zou, Yun, et al.
Publicado: (2020)

Role of the clarithromycin immune modulator activity on abdominal microhemodynamics and mortality in severe sepsis
por: Jesus, FRE, et al.
Publicado: (2012)

Adverse events with quetiapine and clarithromycin coprescription: A population‐based retrospective cohort study
por: Yau, Kevin, et al.
Publicado: (2023)

No dose-response relationship of clarithromycin utilization on cardiovascular outcomes in patients with stable coronary heart disease: Analysis of Taiwan’s national health insurance claims data
por: Yu, Ben-Hui, et al.
Publicado: (2022)

Predictive Value of Cumulative Blood Pressure for All-Cause Mortality and Cardiovascular Events
por: Wang, Yan Xiu, et al.
Publicado: (2017)

Mycobacterium kansasii Subtype I Is Associated With Clarithromycin Resistance in China
por: Li, Yanming, et al.
Publicado: (2016)

Fixed drug eruption due to clarithromycin
por: Malkarnekar, Santoshi Balkrishna, et al.
Publicado: (2013)

Successful Treatment of Eosinophilic Gastroenteritis with Clarithromycin
por: Ohe, Masashi, et al.
Publicado: (2012)

Clarithromycin-induced Seizures and Status Epilepticus
por: Seetharam, Raghavendra, et al.
Publicado: (2021)

The impact of chronic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan
por: Kuo, Chin-Sung, et al.
Publicado: (2017)

Carotid Atherosclerosis Progression and Risk of Cardiovascular Events in a Community in Taiwan
por: Chen, Pei-Chun, et al.
Publicado: (2016)

NT-ProBNP Predicts Total Mortality, Emergency Department Visits, Hospitalization, Intensive-Care Unit Admission, and Cardiovascular Events in Hemodialysis Patients
por: Chen, Yi-Hsin, et al.
Publicado: (2019)

The relationships between step count and all-cause mortality and cardiovascular events: A dose–response meta-analysis
por: Sheng, Mingxin, et al.
Publicado: (2021)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
por: Peterson, Linda R., et al.
Publicado: (2018)

The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis
por: Sholeh, Mohammad, et al.
Publicado: (2023)

Clarithromycin-induced rhabdomyolysis: a case report
por: Pasqualetti, Giuseppe, et al.
Publicado: (2012)

Clarithromycin reverses sepsis-induced immunoparalysis of monocytes
por: Raftogiannis, M, et al.
Publicado: (2009)

Preparation and In Vitro, In Vivo Evaluation of Clarithromycin Microcapsules
por: Hu, Liandong, et al.
Publicado: (2010)

Pharmacokinetic interaction of ketoconazole, clarithromycin, and midazolam with riociguat
por: Becker, Corina, et al.
Publicado: (2013)

Preliminary Study of Interaction of Clarithromycin with Tacrolimus in Cats
por: KATAYAMA, Masaaki, et al.
Publicado: (2014)

Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin
por: Ohe, Masashi, et al.
Publicado: (2016)

Successful treatment with clarithromycin for patients with polymyalgia rheumatica
por: Ohe, Masashi, et al.
Publicado: (2014)

Effectiveness of clarithromycin in patients with yellow nail syndrome
por: Matsubayashi, Sachi, et al.
Publicado: (2018)

Clarithromycin in Post COVID-19 Organizing pneumonia
por: Ayub, Irfan Ismail, et al.
Publicado: (2022)

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
por: Feng, Zi-Han, et al.
Publicado: (2019)

Prognostic Utility of Soluble TREM‐1 in Predicting Mortality and Cardiovascular Events in Patients With Acute Myocardial Infarction
por: Wang, Yun Kai, et al.
Publicado: (2018)

Intra-Amniotic Infection with Ureaplasma parvum Causes Preterm Birth and Neonatal Mortality That Are Prevented by Treatment with Clarithromycin
por: Motomura, Kenichiro, et al.
Publicado: (2020)

Clarithromycin prevents preterm birth and neonatal mortality by dampening alarmin-induced maternal–fetal inflammation in mice
por: Galaz, Jose, et al.
Publicado: (2022)

Framingham Risk Score with Cardiovascular Events in Chronic Kidney Disease
por: Chen, Szu-Chia, et al.
Publicado: (2013)

Association of the Coexistence of Somnipathy and Diabetes With the Risks of Cardiovascular Disease Events, Stroke, and All‐Cause Mortality: A Systematic Review and Meta‐analysis
por: Yang, Xiu Hong, et al.
Publicado: (2022)

Estimation and application of population attributable fraction in ecological studies
por: Lin, Cheng-Kuan, et al.
Publicado: (2019)

Ideal Cardiovascular Health and Risk of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis of Prospective Studies
por: Radovanovic, Milan, et al.
Publicado: (2023)

Association of Longitudinal Patterns of Habitual Sleep Duration With Risk of Cardiovascular Events and All-Cause Mortality
por: Wang, Yun-He, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kpl7p91j8va8r3hus509evd8p4